Latest filing published 03 Apr 2026 for Turn Therapeutics Inc..
Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
All five of the open-market trades filed by Arthur F. Golden are purchases, and no sale is recorded. They add up to EUR 632,644, with a median of EUR 86,073, spread over two companies where Arthur F. Golden sits as a director.
The largest were EUR 240,200 on November 8, 2023 and EUR 225,786 on March 10, 2020, both at Emerson Electric Co, followed by EUR 86,073 on October 23, 2025 at Turn Therapeutics Inc. Emerson Electric accounts for 10 filings including 2 purchases; Turn Therapeutics for 5 filings including 3 purchases. There are also 9 share grants and 1 filing of another kind.
Of the 15 filings published between February 4, 2016 and April 3, 2026, 4 fall in the last twelve months, 3 of them purchases. The year 2025 also holds 4. Filings appear a median of 2 days after the trade.
Golden has 3, 2 and 1 own market trades within 30 days of colleagues, in that order. All of them in the same direction. The colleagues, in the same order: Zuraiz Chaudhary (Turn Therapeutics Inc.), Abraham Chesed (Turn Therapeutics Inc.) and James Morgan McKelvey Jr. (Emerson Electric Co).
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
15 of 15 declarations